Reuters -- Roche Holding AG’s MabThera was more effective in treating rheumatoid arthritis (RA) patients than other drugs with a more traditional mode of action, the Swiss drugmaker said on Wednesday.
Reuters -- Roche Holding AG’s MabThera was more effective in treating rheumatoid arthritis (RA) patients than other drugs with a more traditional mode of action, the Swiss drugmaker said on Wednesday.